← Back to Search

Behavioral Intervention

Mindfulness Therapy for Insomnia (Project WISHES Trial)

N/A
Waitlist Available
Led By Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8 and week 16
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to improve the health of Black women by using a mindfulness-based sleep intervention to reduce stress and sleep-related health issues."

Who is the study for?
This trial is for Black women who are experiencing insomnia and may have cardiometabolic syndrome, which includes conditions like heart disease and diabetes. Participants should be interested in trying a mindfulness-based therapy to improve their sleep.
What is being tested?
The study is testing Mindfulness-Based Therapy for Insomnia (MBTI), aiming to reduce stress and the risk of diseases related to poor sleep among participants by teaching them techniques to enhance their sleep quality.
What are the potential side effects?
Mindfulness-based therapy typically does not involve medication, so physical side effects are rare. However, some individuals might experience emotional discomfort as they confront stressful thoughts during practice.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8 and week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 and week 16 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Intervention (AIM)
Change in Insomnia Severity
Change in Perceived Stress
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MBTIExperimental Treatment1 Intervention
Participants randomized to MBTI group.
Group II: ControlActive Control1 Intervention
Participants randomized to waitlist control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-based therapy for insomnia (MBTI)
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Department of Health and Human ServicesFED
232 Previous Clinical Trials
935,363 Total Patients Enrolled
Yale UniversityLead Sponsor
1,927 Previous Clinical Trials
3,031,392 Total Patients Enrolled
Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAANPrincipal InvestigatorYale University School of Nursing
~227 spots leftby Jul 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top